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Summary: The urinary distribution and relative proportions of the four Coproporphyrin isomers I—IV were
investigated in 50 patients suffering from hepatic and erythropoietic types of hereditary porphyrias. A highly
efficient sample preparation method was applied to isolate urinary coproporphyrins, the isomer ratios of
which were quantitated by isocratic ion-pair high-performance liquid chromatography. Results showed a
significant decrease (p < 0.001) of the proportion of Coproporphyrin I in acute hepatic porphyria (acute
intermittent porphyria, hereditary coproporphyria, variegate porphyria, porphobilinogen synthase deficiency
porphyria) as compared with chronic hepatic porphyria (porphyria cutanea tarda, chronic hepatic porphyria
type B and C) (13.2 ± 5.3%, χ ± S.D., vs. 31.4 ± 11.5%). Conversely, the proportion of isomer III was
significantly higher (p < 0.001) in acute hepatic porphyria than in chronic hepatic porphyria (80.9 + 5.2%
vs. 62.2 + 10.9%). As expected, the highest level of Coproporphyrin I (90.0 ± 1.9%) was found in congenital
erythropoietic porphyria.
The atypical coproporphyrins II and IV were detected in all types of porphyria analysed and ranged from
0.2 to 9.0%; no significant differences were seen between acute and chronic hepatic porphyrias. The diagnostic
importance of the isomer ratios of coproporphyrins I and III has been confirmed in our study, while the
significance of the atypical Coproporphyrin isomers II and IV is still unclear at present.
the haem biosynthetic enzymes in blood cells help to
Porphyrias are caused by deficiencies of haem bio- identify the nature of the hereditary defect (1, 2).
synthetic enzymes (fig. 1). Characteristic excretion Additional diagnostic information can be obtained
patterns of porphyrins and pprphyriri precursors — for some porphyrias when the ratios of the naturally
reflecting the respective enzymatic defect — are ob- occurring isomers of series I and III are determined
served in these conditions. (3). Alterations of the normal ratios of copropor-
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Fig. 1. Inherited enzyme blocks in the porphyrias. (Slightly modified from I.e. (28)).
phyrinurias often show characteristic isomer ratios
which may originate from lead intoxication (5), some
liver diseases, like alcohol- and protoporphyrin-in-
duced cholestasis (7, 8) or hereditary hyperbilirubin-
aemias such as Rotor's syndrome and Dubin-Johnson
syndrome (9). Thus, the respective isomer ratios are
valuable tools for the differential diagnosis of these
disorders (10).
The development of enhanced high-performance liq-
uid Chromatographie (HPLC) methods enabled the
simultaneous resolution of the naturally occurring
type I and type III isomers in the series from uro- to
coproporphyrin in a single Chromatographie run (11,
12). In addition, complete resolution of the four co-
proporphyrin isomers I —IV was achieved under iso-
cratic conditions (12, 13). However, the atypical iso-
mers of the series II and IV were previously thought
to be non-existent in biological materials (14). Re-
cently, we were able to detect small amounts of co-
proporphyrin II and IV in human urine (15) and feces
(16). These symmetrically substituted isomers are
mainly formed by non-enzymatic isomerization of
porphyrinogens in relatively acidic urines (17).
In this study, we investigated for the first time the
isomeric composition of coproporphyrins I— IV in
urine of patients suffering from the common types of
hereditary porphyria. The individual isomer ratios
were determined in order to clarify their potential in
the differential diagnosis of porphyrias.
Materials and Methods
Patients
We analysed the isomer ratios of coproporphyrins I—IV in
urine of patients suffering from acute intermittent porphyria
(N = 20), hereditary coproporphyria (N = 6), variegate por-
phyria (N = 3), porphobilinogen synthase (synonym: 5-ami-
nolaevuiinic acid dehydratase) deficiency porphyria (N = 1),
porphyria cutanea tarda (N = 10), chronic hepatic porphyria
(type B and C, N = 5), congenital erythropoietic porphyria
(N = 3), and protoporphyria (N = 2). Diagnosis of the re-
spective porphyrias was based on the characteristic biochemical
constellations (1 — 3,8) in connection with the clinical symptoms
in overt cases.
Table 1 shows the excretion of urinary porphyrin precursors
and porphyrins of four porphyria patients. The patients with
acute intermittent porphyria, porphobilinogen synthase defi-
ciency porphyria and congenital erythropoietic porphyria were
in a non-acute phase at the time of investigation, whereas the
patient with porphyria cutanea tarda was in a clinically manifest
phase. Due to the homozygous status of the patients with
porphobilinogen synthase deficiency 'jJorphyria and congenital
erythropoietic porphyria, their metabolite excretion is exces-
sively increased (tab. 1).
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Tab. 1. Urinary porphyrin
Porphyria
Porphyrin precursors
(μηοΙ/24 h)
δ-Aminolaevulinic acid
Porphobilinogen
Porphyrins (nmol/24 h)
Uroporphyrin
Heptacarboxylic
porphyrin
Hexacarboxylic
porphyrin
Pentacarboxylic
porphyrin
Coproporphyrin
precursors and porphyrins in four patients with various types of porphyria.
Acute intermittent
pofphyria, female,
38 years old, non-
acute phase
(fig. 3a)
175
315
950
45
33
70
285
Porphyria cutanea
tarda, female, 43
years old, manifest
phase
(fig. 3b)
40
3
2180
1290
24
265
205
PBG synthase defi-
ciency porphyria,
male, 33 years old,
non-acute phase
(fig. 3c)
1018
8
49
25
11
122
2834
Congenital erythro-
poietic porphyria,
male, 26 years old,
non-acute phase
(fig. 3d)
21
2
4918
543
279
1256
6878
Controls,
upper
reference
limit*
49
8
29
4
3
6
119
According to Doss (29)
Urines
24 h-urine samples were collected in dark brown bottles and
kept frozen until analysis.
Sample preparation
Urinary total coproporphyrins were isolated by the method
described previously (18) with the following modification: the
TLC separation of the individual porphyrin methyl esters was
performed on Kieselgel 60 (Merck, Darmstadt, Germany) using
n-hexane/dichloromethaiie/acetone (41 +41 -f 18, by vol.) as
the solvent (19).
Coproporphyrins
α>
α>
er
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Fig. 2. Isocratic ion-pair HPLC separation of a synthetic mix-
ture of Coproporphyrin isomers I—IV containing 14.1 %
of type I, 52.1% of type III, 22.4% of type IV and
11.4% of type II.
Briefly, urine samples (5 to 10 ml) were oxidized with iodine,
and porphyrins were then adsorbed on talc, esterified with
methanol/conc. sulphuric acid, and the porphyrin methyl esters
separated by TLC (see above). After hydrolysis, the free copro-
porphyrins were further purified by adsorption on Sep-Pak Qg
cartridges (Waters, Eschborn, Germany) and eluted with meth-
anol/acetone (1 + 1, by vol.).
High-performance liquid Chromatographie analysis
Coproporphyrins I —IV were separated by isocratic ion-pair
HPLC on a 5 μπι-LiChrosorb RJP-18 column (Merck) using
tetrabutylammonium phosphate as the ion-pairing reagent (18).
Percentages of Coproporphyrin isomers were calculated from
peak area ratios of the individual isomers.
Statistical analysis
The Kolmogorov-Smirnov test (20) was used to assess statistical
significance between different variable classes.
Results and Discussion
High-performance liquid Chromatographie
separation and quantitation of
coproporphyrins I — I V
Simultaneous separation of all four Coproporphyrin
isomers was achieved by means of isocratic ion-pair
HPLC. Figure 2 shows the baseline separation of a
synthetic mixture of coproporphyrins I —IV. The iso-
mer ratios derived from the respective peak areas were
determined with a coefficient of variation of 4%
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Isolation of urinary coproporphyrins
The sampling procedure for urinary coproporphyrins
was started with an oxidation step to prevent possible
non-enzymatic isomerization of porphyrinogens un-
der relatively acidic conditions (17, 21). The resulting
porphyrins, however, are absolutely stable to further
isomerization (21). Porphyrins were then isolated by
adsorption on talc and TLC separation on silica gel
of the respective methyl esters. For further purifica-
tion, the free coproporphyrins were passed through a
Ci8-modified silica gel cartridge prior to HPLC anal-
ysis. .This extensive sampling method was developed
in order to obtain accurate chromatograms which
were not obscured by interfering substances. This
procedure was necessary to avoid erroneous results
caused by contaminants co-eluting in the copropor-
phyrin region, especially in the case of urine samples
from patients with chronic hepatic porphyria.
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Fig. 3. Isocratic ion-pair HPLC separation of urinary coproporphyrin isomers I—IV (percentage of total coproporphyrins) from
various porphyria patients.
a = acute intermittent porphyria, I (14.0), III (79.9), IV (4.1), II (2.0).
b = porphyria cutanea tarda, I (31.7), III (63.5), IV (3.3), II (1.5).
c = porphobilinogen synthase deficiency porphyria, I (5.4), III (83.4), IV (7.8), II (3.4).
d = congenital erythropoietic porphyria, I (91.9), III (7.3), IV (0.6), II (0.2).
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The final yield of total coproporphyrins after extrac-
tion, esterification, TLC separation and hydrolysis
varied somewhat, depending on the type of urine
analysed, and was between 69 and 83%.
To.check the recovery rate of the individual copro-
porphyrin isomers we analysed a relatively uncontam-
inated urine from a patient with acute intermittent
porphyria by using two different methods. First, the
urinary porphyrins were simply adsorbed onto a Ci8-
modified silica gel cartridge, eluted with methanol-
acetone, and coproporphyrin isomers were estimated
directly by isocratic ion-pair HPLC, resulting in
15.1% of type I, 79.5% of type III, 1.5% of type II
and 3.9% of type IV. In a second series the same
urine was analysed four times with the complete sam-
ple preparation method as described. Here we ob-
tained 14.2 ±1.1% (x + S.D.) isomer I, 80.5
± 2.4% isomer III, 1.6 ± 0.3% isomer II and 3.7
+ 0.4% isomer IV. Thus we conclude that the clean-
up procedure did not alter the original isomer com-
position of the urine samples.
The chromatograms of urinary coproporphyrin iso-
mers I—IV from patients with acute intermittent por-
phyria (fig. 3a), porphyria cutanea tarda (fig. 3b),
porphobilinogen synthase deficiency porphyria (fig.
3c) and congenital erythropoietic porphyria (fig. 3d)
clearly demonstrate the high efficiency of this sample
preparation procedure. The clinical and biochemical
data of the respective patients are presented in table 1.
Isomeric composition of coproporphyrins
I — I V in porphyric urines
The isomeric composition of coproporphyrins I—IV
was analysed in 50 urine specimens from porphyria
patients. Mean values, standard deviations and ranges
of the isomers I —IV in these samples are summarized
in table 2. The isomeric composition of copropor-
phyrins I —IV in acute hepatic porphyrias (acute in-
termittent porphyria, hereditary coproporphyria, var-
iegate porphyria, porphobilinogen synthase deficiency
porphyria) versus chronic hepatic porphyrias (por-
phyria cutanea tarda, chronic hepatic porphyria) is
compared in table 3.
In normal urines, coproporphyrins I and III account
for approximately 25% and 75%, respectively, of the
total porphyrins (1). In acute hepatic porphyrias, the
percentage of coproporphyrin I (13.2 + 5.3%, mean
+ S. D.) was significantly lower than in chronic he-
patic porphyrias (31.5 ± 11.5%, p < 0.001) (tab. 3).
On the other hand, the proportion of isomer III was
markedly higher in acute hepatic porphyrias com-
pared with that in chronic types (80.9 ± 5.2% vs.
62.2 ± 10.9%, p < 0.001) (tab. 3). These findings are
in agreement with results described previously by Doss
& Schermuly (3). As expected, the highest percentage
of coproporphyrin I was detected in the three cases
with congenital erythropoietic porphyria (90.0
± 1.9%). Consequently, coproporphyrin III levels
were found here as low as 8.6 + 1.2% (tab. 2). Uri-
Tab. 2. Isomeric composition of urinary coproporphyrins I—IV in various porphyrias. Data are expressed as percentage of total
urinary coproporphyrins.
Porphyria N Coproporphyrins
Acute intermittent porphyria
Hereditary coproporphyria
Variegate porphyria
Porphobilinogen synthase deficiency porphyria
Porphyria cutanea tarda
Chronic hepatic pprphyria (type B/C)
Congenital erythropoietic porphyria
Protoporphyria
20
6
3
1
10
5
3
2
I*
13.5 ± 5.4
(7-25)
14.9 + 4.3
(9-22)
9.5 + 4.7
(6-15)
5.4
28.5 ± 12.0
(16-55)
37.1 ± 9.1
(24-47)
90.0 ± 1.9
(88-92)
86.0/65.6
III*
80.7+ 4.9
(71-89)
79.6 ± 5.6
(75-89)
83.9+ 9.4
(73-90)
83.4
64.9 ± 11.8
(39-80)
56.8 + 6.8
(51-67)
8.6 ± 1.2
(7.3-9.8)
12.0/28.9
II*
1.8 + 0.9
(0.2-3.9)
1.8 ± 1.7
(0.3-4.9)
1.8 + 1.1
(1.1-3.0)
3.4
2.1 + 1.1
(0.2-3.9)
1.7 ± 1.0
(0.5-2.7)
0.4 + 0.2
(0.2-0.5)
0.5/1.5
IV*
4.0 + 2.1
(0.9-8.6)
3.7 + 2.7
(0.6-7.1)
4.8 + 3.6
(2.7-9.0)
7.8
4.5 ± 2.2
(0.5-7.9)
4.4 + 2.0
(1.1-6.5)
1.0 ± 0.4
(0.6-1.4)
1.5/4.0
* mean value ± S. D. (range).
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Tab. 3. Comparison of the isomeric composition of urinary coproporphyrins I -IV in acute and chronic hepatic porphyria. Data
are expressed as percentage of total urinary coproporphyrins.
Porphyria N Coproporphyrins
IIP IV*
Acute hepatic porphyria
Acute intermittent porphyria, hereditary coproporphy-
ria, variegate porphyria, porphobilinogen synthase
deficiency porphyria
Chronic hepatic porphyria
30 13.2 ± 5.3 80.9 ± 5.2 1.8 + 1.1 4.1+2.3
(5-25) (71-90) (0.2-4.9) (0.6-9.0)
Porphyria cutanea tarda, chronic hepatic porphyria 15 31.4 ±11.5(16-55)
p < 0.001
62.2 + 10.9
(39-80)
p < 0.001
2.0 ± 1.0
(0.2-3.9)
p > 0.6
(N. S.)
4.4 + 2.1
(0.5-7.9)
p > 0.3
(N. S.)
* mean value + S. D. (ränge).
nary coproporphyrin isomer ratios of patients suffer-
ing from protoporphyria are influenced by the degree
of impaired liver function (8). Isomer I increases in
cases with protoporphyrin-induced cholestatic liver
disease (8). The atypical coproporphyrin isomers II
and IV were detectable in all the types of porphyria
analysed. They ranged from 0.2 to 9.0% of total
coproporphyrins (tab. 2). Normal urines contain ca.
2% of isomer II and ca. 4% of isomer IV (15). The
highest level of coproporphyrin II (4.9%) was found
in the urine of a patient with hereditary copropor-
phyria, while the highest percentage of copropor-
phyrin IV (9.0%) was observed in a case with varie-
gate porphyria. Isomers II and IV were rather low in
urine of patients with congenital erythropoietic por-
phyria and protoporphyria (tab. 2).
In contrast to isomers I and III, there were no signif-
icant differences between the levels of isomer II (1.8%
vs. 2.0%, p > 0.6) and isomer IV (4.1% vs. 4.4%,
p > 0.3) in acute and chronic hepatic porphyrias
(tab. 3).
Formation of the atypical coproporphyrins
II and IV
Previously, we showed a marked increase of copro-
porphyrins II and IV in acidic urines sampled from
healthy controls, due to the high content of porphyr-
inogens in non-porphyric urines (17). In urine samples
of porphyric patients, however, the concentrations of
porphyrinogens are significantly lower (22), and there-
fore the pH-dependent formation of the isomers II
and IV is markedly reduced.
With the exception of congenital erythropoietic por-
phyria and protoporphyria, we found comparable
percentages of coproporphyrins II and IV in por-
phyric and non-porphyric urines. In addition, a con-
stant isomer ratio of approximately 1 : 2 was observed
for coproporphyrins II and IV in acute and chronic
hepatic porphyrias (tab. 1). Such a ratio indicates the
non-enzymatic formation of these isomers, because
the same ratio is found in the so-called statistical
mixture of isomers I--IV, when porphyrinogens are
isomerized under thermodynamically controlled con-
ditions (21).
Diagnostic value of coproporphyrin isomer
ratios
Study of the urinary coproporphyrin isomers of pa-
tients with acute and chronic hepatic porphyrias re-
vealed highly significant differences in the distribution
of isomers I and III. These indices may therefore
contribute to the differentiation between acute and
chronic hepatic porphyrias. In contrast to the isomers
I and III, the atypical isomers II and IV are not
suitable for the differential diagnosis of these por-
phyrias.
The high proportion of coproporphyrin I in urine of
patients with congenital erythropoietic porphyria is a
diagnostically important indicator for the underlying
enzymatic defect, although comparably high levels
can be observed in patients with Dubin-Johnson syn-
drome (10). Therefore, additional studies on the iso-
mer ratios in cases of secondary coproporphyrinurias
might be helpful for the differential diagnosis of such
diseases.
Explanation of increased coproporphyrin
excretion in porphobilinogen synthase
deficiency porphyria
The high increase of coproporphyrin III in porpho-
bilinogen synthase deficiency porphyria is explained
by a compensatory counterregulatory enhancement
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of porphyrinogen biosynthesis (23). Coproporphyri-
nogen oxidase activity is not reduced in this type of
porphyria. An increased excretion of coproporphyrin
III has also been observed in acute intermittent por-
phyria (3). However, there is no deficiency of copro-
porphyrinogen oxidase in acute intermittent por-
phyria, so that a compensatory mechanism that ex-
aggerates the enzymatic defect has been proposed as
background for this increased porphyrin biosynthesis
(24). Furthermore, the metabolic changes can be im-
itated by oral δ-aminolaevulinic acid loading in hu-
mans, resulting in an excessive increase of urinary
coproporphyrin excretion, containing about 90% of
isomer III (3). These observations show clearly that
coproporphyrin isomer III is the main component of
the urinary porphyrins derived from excessive
amounts of δ-aminolaevulinic acid of endogenous or
exogenous origin.
Doss porphyria versus acute intermittent
porphyria
Porphobilinogen synthase deficiency porphyria was
first described 1979 by Doss et al. (23). This acute
hepatic porphyria represents a special entity with a
nearly complete enzyme deficiency, which differs from
that of acute intermittent porphyria (fig. 1). Por-
phobilinogen synthase deficiency porphyria becomes
clinically manifest with an acute porphyria syndrome
(23) only in the homozygous state. In contrast to
acute intermittent porphyria, heterozygotes are clini-
cally non-affected (25). The enzyme defect could be
traced over three generations (25). Immunological
characterization of non-catalytic enzyme (cross react-
ing immunological material (CRIM)-positive) showed
that a structurally modified enzyme is present (26).
Recently, cloning and expression of the defective genes
from the patient with porphobilinogen synthase de-
ficiency have been reported (27). Two separate point
mutations were found in each porphobilinogen syn-
thase allele, suggesting a compound heterozygosity as
the molecular basis for this rare type of acute por-
phyria (27).
Conclusion
In this study, we confirmed the occurrence of in-
creased proportions of urinary coproporphyrin III in
acute hepatic porphyria as compared with chronic
hepatic porphyria (3). In contrast, the proportion of
coproporphyrin I was found to be significantly lower
in acute hepatic porphyria than observed in chronic
hepatic porphyria.
The percentage of the atypical coproporphyrin iso-
mers II and IV, which are probably formed non-
enzymatically, sometimes exceeds 10% of total copro-
porphyrins in individual cases. This unexpected find-
ing has not been reported previously. Additional stud-
ies are required on the biogenesis of the atypical
isomers under physiological conditions. It is assumed
that these isomers arise from rearrangement of the
tetrapyrrolic ring after urine has been excreted by the
kidney. In urine of healthy controls, we were able to
demonstrate a stringent pH-dependency of copropor-
phyrin isomer ratios (17). The pathobiochemistry of
altered porphyrin isomer ratios has yet to be eluci-
dated by further investigations.
High proportions of isomer I either originate from an
enzymatic defect, as in congenital erythropoietic por-
phyria (6), or they are formed non-enzymatically, as
in Dubin-Johnson syndrome (8) and in protoporphyria
(10). In the latter disturbances, membrane and trans-
port processes play an important role in the alteration
of the respective porphyrin isomer ratios.
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